Since 2021, various health associations and experts  have warned of a worrying increase in the incidence of several diseases: atypical cancers, neurological disorders, autoimmune diseases, and heart disease. While some hospital departments have noticed this increase, they are reluctant to discuss it publicly.

The available data speaks for itself. Reports indicate that COVID-19 vaccines account for 12% of global pharmacovigilance, and nearly 12,000 studies are currently underway to investigate potential links to various diseases. In France, the National Agency for Medicines Safety (Agence Nationale de Sécurité du Médicament) recorded no fewer than 193,934 adverse reaction reports, including 1,635 deaths, in its June 2023 report. These figures, based on a passive pharmacovigilance system, likely underestimate the true situation considerably, according to numerous observers.

This situation raises fundamental questions about the transparency of health authorities and the risk-benefit ratio of these vaccines, developed so hastily. A document published by Pfizer under legal pressure finally offers a more complete picture of the risks faced by millions of people worldwide who receive these vaccines.